版本:
中国

BRIEF-Sanofi sees Soliqua costing about same as a GLP-1 drug in U.S.

Nov 22 Sanofi :

* Says expects daily wholesale acquisition cost of new diabetes drug Soliqua will be similar to daily price of a GLP-1 in U.S.

* Comment made by spokesman in response to Reuters inquiry Further company coverage: (Reporting by UK bureau)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐